Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid von Krasny, Sophia, Yan, Cynthia, Hartley, Sigan L., Handen, Ben L., Wisch, Julie K., Boehrwinkle, Anna H., Ances, Beau M., Rafii, Michael S.

Volltext

Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation von Lao, Patrick J., Handen, Ben L., Betthauser, Tobey J., Cody, Karly A., Cohen, Annie D., Tudorascu, Dana L., Stone, Charles K., Price, Julie C., Johnson, Sterling C., Klunk, William E., Christian, Bradley T.

Volltext

Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population von Lao, Patrick J, Handen, Ben L, Betthauser, Tobey J, Mihaila, Iulia, Hartley, Sigan L, Cohen, Annie D, Tudorascu, Dana L, Bulova, Peter D, Lopresti, Brian J, Tumuluru, Rameshwari V, Murali, Dhanabalan, Mathis, Chester A, Barnhart, Todd E, Stone, Charles K, Price, Julie C, Devenny, Darlynne A, Mailick, Marsha R, Klunk, William E, Johnson, Sterling C, Christian, Bradley T

Volltext

Double-Blind, Placebo-Controlled Study of Risperidone for the Treatment of Disruptive Behaviors in Children With Subaverage Intelligence von Aman, Michael G., De Smedt, Goedele, Derivan, Albert, Lyons, Ben, Findling, Robert L., Risperidone Disruptive Behavior Study Group

Volltext